{"id":8927,"date":"2021-12-17T03:38:40","date_gmt":"2021-12-17T08:38:40","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/vente-chaude-plecanatide-cas-467426-54-6-utilisation-pour-traiter-la-constipation-idiopathique-chronique-cic\/"},"modified":"2021-12-17T03:38:40","modified_gmt":"2021-12-17T08:38:40","slug":"vente-chaude-plecanatide-cas-467426-54-6-utilisation-pour-traiter-la-constipation-idiopathique-chronique-cic","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fr\/product\/vente-chaude-plecanatide-cas-467426-54-6-utilisation-pour-traiter-la-constipation-idiopathique-chronique-cic\/","title":{"rendered":"Vente chaude Plecanatide CAS 467426-54-6 Utilisation pour traiter la constipation idiopathique chronique (CIC)"},"content":{"rendered":"<h2><strong>Vente chaude Plecanatide CAS 467426-54-6 Utilisation pour traiter la constipation idiopathique chronique (CIC)<\/strong><\/h2>\n<p>Nom du produit\u00a0: Plecanatide<br \/>\nSynonymes\u00a0: Plecanatide;ASN-ASP-GLU-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU(DISULFIDE BOND CYS1&amp;CYS3, CYS2&amp;CYS4);Pl\u00e9canatide Impuret\u00e9;L-Leucine, L-asparaginyl-L-\u03b1-aspartyl-L-\u03b1-glutamyl-L-cyst\u00e9inyl-L-\u03b1-glutamyl-L-leucyl-L-cyst\u00e9inyl-L-valyl-L- asparaginyl-L-valyl-L-alanyl-L-cyst\u00e9inyl-L-thr\u00e9onylglycyl-L-cyst\u00e9inyl-, cyclique (4\u219212),(7\u219215)-bis(disulfure);Pl\u00e9canatide fandachem;Pl\u00e9canatide impuret\u00e9;Pl\u00e9canatide USP\/ EP\/BP;Prikanatide<br \/>\nCAS\u00a0: 467426-54-6<br \/>\nMF\u00a0: C65H104N18O26S4<br \/>\nMW\u00a0: 1681.89<br \/>\nMol File\u00a0: 467426-54-6.mol<\/p>\n<p>Plecanatide est un nouveau m\u00e9dicament qui affecte l&#39;enzyme guanylate cyclase, stimulant la s\u00e9cr\u00e9tion de liquide intestinal et acc\u00e9l\u00e9rant les selles. Le peptide oral, compos\u00e9 de 16 acides amin\u00e9s, est con\u00e7u pour imiter la guanosine urinaire, un peptide gastro-intestinal humain. D\u00e9velopp\u00e9 \u00e0 l&#39;origine par Callisto Pharmaceuticals aux \u00c9tats-Unis et transf\u00e9r\u00e9 \u00e0 Synergy Pharmaceuticals pour le d\u00e9veloppement, le proca\u00efnatide a \u00e9t\u00e9 approuv\u00e9 pour la commercialisation par la Food and Drug Administration (FDA) des \u00c9tats-Unis le 19 janvier 2017 pour le traitement de la CIC chez l&#39;adulte. Le proca\u00efnatide est un analogue de l&#39;uroguanosine. (uroguanyline) et contient un 16 C&#39;est un analogue de l&#39;uroguanyline, un peptide cyclique contenant 16 acides amin\u00e9s, et a la fonction d&#39;un agoniste des r\u00e9cepteurs de la guanylate cyclase qui favorise l&#39;excr\u00e9tion urinaire de sodium, r\u00e9gule les ions acido-basiques dans le tractus gastro-intestinal, induit le liquide transport dans le tractus gastro-intestinal et augmente le p\u00e9ristaltisme du tractus gastro-intestinal.<\/p>\n<p>Traduit avec www.DeepL.com\/Translator (version gratuite)<\/p>\n<p> <strong>Fonction et application du pl\u00e9canatide<\/strong><br \/>\nProcainide est un agoniste des r\u00e9cepteurs de la guanylatecyclase-C (GC-C) qui favorise l&#39;excr\u00e9tion urinaire de sodium, r\u00e9gule les ions acide-base dans le tractus gastro-intestinal, induit le transport de fluide dans le th e tractus gastro-intestinal, et augmente le p\u00e9ristaltisme dans le tractus gastro-intestinal, et est indiqu\u00e9 pour le traitement de CIC chez les adultes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nom du produit : Pl\u00e9canatide <strong><br \/>\nCAS : 467426-54-6<br \/>\nMF : C65H104N18O26S4<br \/>\nMW : 1681.89<br \/>\nMol Dossier : 467426-54-6.mol<\/strong><\/p>\n","protected":false},"featured_media":2164,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[452],"product_tag":[805],"class_list":{"0":"post-8927","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptide-du-systeme-gastro-intestinal","7":"product_tag-plecanatide-cas-467426-54-6-use-for-treat-chronic-idiopathic-constipation-fr","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product\/8927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/comments?post=8927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media\/2164"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media?parent=8927"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_brand?post=8927"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_cat?post=8927"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_tag?post=8927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}